| ¿µ¹® | hydrops | ÇÑ±Û | ¼öÁ¾ |
|---|---|---|---|
| ¼³¸í | 1. ½ÅüÀÇ Á¶Á÷ °£°ÝÀ̳ª ü° ¾È¿¡ ¸²ÇÁ¾×, Àå¾× µîÀÌ ¸¹ÀÌ ±«¾î ÀÖ¾î ¸öÀÌ º×´Â º´. ÄáÆÏ¼º, ½ÉÀ强, ¿µ¾çÀå¾Ö¼º µîÀÌ ÀÖ´Ù. 2. ¾µ°³ÀÇ ¸ñºÎÀ§³ª ¾µ°³±æÀÌ ¿ÏÀüÈ÷ Æó¼âµÇ¾úÀ» ¶§ Åõ¸íÇÑ Á¡¾× ºÐºñ¹°¿¡ ÀÇÇØ ¾µ°³±æÀÌ È®ÀåÇÑ °ÍÀ» ÀÏÄ´µ¥ ¾µ°³µ¹À» µ¿¹ÝÇÏ´Â °æ¿ì°¡ ¸¹´Ù. |
||
| ¿µ¹® | erythroblastosis fetalis | ÇÑ±Û | žÆÀû¸ð±¸Áõ |
|---|---|---|---|
| ¼³¸í | ¾î¸Ó´Ï¿¡¼ »ý»êµÈ žÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ ŹÝÀ» °Ç³Ê¿Í¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». Áï ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼ ¸¸µé¾îÁ®¼ À̰ÍÀÌ Å¹ÝÀ» ÅëÇØ¼ žƿ¡°Ô ³Ñ¾î°¡¸é žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±« µÇ¾î¼ °á±¹ ºóÇ÷ÀÌ »ý±ä °ÍÀ» žÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ°ú ABO Àû¸ð±¸Áõ·Î ³ª´ ¼ö°¡ ÀÖ´Ù. 1) Rh Àû¸ð±¸ÁõÀûÇ÷±¸ÀÇ Ç¥¸é¿¡´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¿©·¯ °¡Áö Ç׿øÀÌ ÀÖ´Ù. ±×Áß D¶ó´Â Ç׿øÀÇ À¯¹«¿¡ µû¶ó¼ Ç÷¾×ÇüÀ» Rh(+) ȤÀº Rh(-)·Î ³ª´«´Ù. Rh(+) Ç÷¾×ÇüÀÇ °æ¿ì¿¡´Â ÀûÇ÷±¸ Ç¥¸é¿¡ D¶ó´Â ¹°ÁúÀÌ Á¸ÀçÇϰí Rh(-)ÀÇ Ç÷¾×ÇüÀÇ °æ¿ì¿¡´Â D¶ó´Â Ç׿øÀÌ ÀûÇ÷±¸ÀÇ Ç¥¸é¿¡ Á¸ÀçÇÏÁö ¾Ê´Â´Ù. ¸¸¾à ¾î¸Ó´Ï°¡ Rh(-)À̰í ÀÓ½ÅµÈ Å¾ư¡ Rh(+)ÀÇ °æ¿ì¿¡ Á¤»óÀûÀ¸·Î žÆÀÇ ÀûÇ÷±¸´Â ŹÝÀ» ÅëÇÏ¿© ¾î¸Ó´ÏÀÇ Ç÷¾×¼ÓÀ¸·Î µé¾î°¥ ¼ö°¡ ¾øÁö¸¸ ºÐ¸¸µµÁß¿¡ ŹÝÀÇ ÀÛÀº °á¼ÕÀ̳ª »óó¸¦ ÅëÇÏ¿© ¸ðüÀÇ ¼øÈ¯ ¼Ó¿¡ µé¾î°¡°Ô µÇ¸é Rh À½¼ºÀÎ ¸ðü¿¡ óÀ½À¸·Î D¶ó´Â Ç׿ø¿¡ ³ëÃâÀÌ µÇ°í ÀÌ Ç׿øÀ» ¿ÜºÎÀÇ ¹°Áú·Î ÀÎÁö¸¦ ÇØ¼ ±×°Í¿¡ ´ëÇÑ Ç×ü¸¦ ¸¸µç´Ù. ±×¸®°í ±× ´ÙÀ½¹ø Àӽſ¡¼ ¸¸¾à Rh(+)¸¦ °¡Áø ¾ÆÀ̸¦ ÀÓ½ÅÇÏ°Ô µÇ¸é ÀÌ Ç×ü°¡ ŹÝÀ» ÅëÇØ¼ žƿ¡°Ô °Ç³Ê°¡¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» ÇÏ¿© ÀûÇ÷±¸ÀÇ ÆÄ±«¸¦ À¯µµÇÑ´Ù. 2) ABO Àû¸ð±¸ÁõÀûÇ÷±¸Ç¥¸é¿¡ Á¸ÀçÇÏ´Â ¿©·¯ °¡Áö Ç׿ø Áß¿¡¼ A, BÇ׿øÀÌ Á¸ÀçÇÑ´Ù. À̰ÍÀ¸·Î Ç÷¾×ÇüÀ» Á¤ÇÏ´Â ¹æ¹ýÀÌ ABOÇü Ç÷¾×ÇüÀÌ´Ù. ABO Àû¸ð±¸ÁõÀº ¾î¸Ó´Ï¿Í žƻçÀÌÀÇ ÀÌ ABO Ç÷¾×ÇüÀÇ ºÎÀûÇÕÀ¸·Î ÀÎÇØ¼ »ý±â´Â °ÍÀ¸·Î ÀÌ¹Ì Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â Ç×ü°¡ ŹÝÀ» ÅëÇØ¼ žƿ¡°Ô °Ç³Ê°¬À» °æ¿ì¿¡ »ý±ä´Ù. Áï ¾î¸Ó´Ï°¡ OÇüÀÇ Ç÷¾×ÇüÀ» °¡Á³À» °æ¿ì¿¡ ¾î¸Ó´Ï´Â Á¤»óÀûÀ¸·Î A, BÀÇ µÎ °¡Áö Ç׿ø¿¡ ´ëÇØ¼ ¸ðµÎ Ç×ü¸¦ °¡Áö°í ÀÖ´Ù. ±×·±µ¥ žư¡ AÇüÀÎ °æ¿ì¿¡ ¾î¸Ó´Ï¿¡ Á¸ÀçÇÏ´Â A¿¡ ´ëÇÑ Ç×ü°¡ ŹÝÀ» ÅëÇØ¼ °Ç³Ê¿ÔÀ» °æ¿ì¿¡ À̰Ͱú žÆÀÇ ÀûÇ÷±¸¿¡ ºÎÂøÀÌ µÇ°í Ç×ü°¡ ºÎÂøÀÌ µÈ ÀûÇ÷±¸´Â ¿ª½Ã ÆÄ±«°¡ µÈ´Ù. ´ëºÎºÐÀÇ °æ¿ì ¾î¸Ó´Ï°¡ OÇü, ¾Æ±â°¡ AÇü, ȤÀº BÇüÀÏ ¶§ ÀϾÙ. ABOÀû¾Æ±¸ÁõÀÇ Áõ¼¼´Â Rh Àû¸ðÁõº¸´Ù °¡º¿ì³ª ÈξÀ ´õ ºó¹øÀÌ ÀϾÙ. ±×·¯³ª Rh Àû¸ð±¸ÁõÀº ù¹øÂ° ¾ÆÀÌ¿¡¼ Àû°Ô »ý±â°í ´ëºÎºÐÀÇ °æ¿ì µÎ¹øÂ° ¾ÆÀÌ¿¡¼ ¸¹ÀÌ »ý±â´Âµ¥ ºñÇÏ¿© ABO Àû¸ð±¸ÁõÀº ¾à 50%°¡ ù ¾Æ±â¿¡¼ º¼ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | neonatal intensive care center | ÇÑ±Û | ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç |
|---|---|---|---|
| ¼³¸í | ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇÏ´Â ±â°ü. |
||
| ¿µ¹® | intensive care unit | ÇÑ±Û | ÁßȯÀÚ½Ç |
|---|---|---|---|
| ¼³¸í | º´¼¼³ª »óó µûÀ§ÀÇ Á¤µµ°¡ ¸Å¿ì ½ÉÇÑ »ç¶÷À» Ä¡·áÇÏ°í µ¹º¼ ¼ö ÀÖµµ·Ï ¸¶·ÃÇÑ ¹æ. È£Èí-¼øÈ¯-´ë»ç µî Á¤½ÅÀû ±Þ¼º±â´É»ó½ÇÀÇ È¯ÀÚ¸¦ Ãë±ÞÇÏ¸ç °·ÂÇÏ°íµµ ÁýÁßÀûÀÎ Áø·á¸¦ ÇÏ´Â ºÎºÐÀÌ´Ù. À§µ¶ÇÑ È¯ÀÚ¿¡ ´ëÇÏ¿©´Â 24½Ã°£ üÁ¦·Î ´ëÀÀÇÑ´Ù. ÃæºÐÈ÷ ÈÆ·ÃÀ» ¹ÞÀº ÀÇ·áÁøÀÌ ¹èÄ¡µÇ¸ç ±â´ÉÀûÀ¸·Î ¼³ºñ°¡ °®Ãß¾îÁ® ÀÖ´Ù. ½É±Ù°æ»öÁõ-È£Èí±â´É»ó½Ç-ÄáÆÏ±â´É»ó½Ç-¼Ò¾Æ-½Å°æ¿Ü°ú°è µî ƯÁ¤È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ´Ù. |
||
| NHF | National Health Federation; National Hemophilia Foundation; nonimmune hydrops fetalis |
|---|---|
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
| E. Fetalis | Erythroblastosis Fetalis |
| MHP | hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1... |
| MIC | maternal and infant care; medical intensive care; Medical Interfraternity Conference; microscopy; mi... |
| NIHF | Non-immune hydrops fetalis |
|---|---|
| EH | Endolymphatic hydrops |
| AMA | Advanced maternal age |
| MCH | Maternal Child Health |
| MSAFP | Maternal Serum Alpha Feto Protein |
| halo sign of hydrops | A discredited roentgenographic sign of foetal hydrops caused by scalp oedema so that a definite corona surrounds the skull. (05 Mar 2000) |
|---|---|
| hydrops | <disease> A name applied to recurrent vertigo accompanied by ringing in the ears (tinnitus) and deafness. A dysfunction of the semi-circular canals (endolymphatic sac) in the inner ear. Symptoms include dizziness, hearing loss (one-sided), vertigo, nausea, vomiting and abnormal eye movements. Treatment includes anticholinergics, antihistamines and other medications which relieve vertigo. Diuretic medications have been used to lower pressure in the endolymphatic sac. (27 Sep 1997) |
| hydrops articuli | <medicine> An effusion of watery liquid into the cavity of a joint. Origin: NL. See Hydro-, 1, and Arthrosis. Source: Websters Dictionary (01 Mar 1998) |
| hydrops foetalis | <embryology, paediatrics> A severe form of the genetic disorder thalassaemia in which all four alpha chain polypeptides making up the haemoglobin molecule (the protein which transports oxygen in the body) are missing due to a defect in the gene which codes for them. As a result, affected individuals die at or before birth. (09 Oct 1997) |
| hydrops ovarii | A collection of fluid in the ovary. Synonym: hydrops ovarii. (05 Mar 2000) |
| hydrops pericardii | An obsolete term for pericardial effusion. (05 Mar 2000) |
| hydrops tubae | Accumulation of serous fluid in the fallopian tube, often an end result of pyosalpinx. Synonym: hydrops tubae. Origin: hydro-+ G. Salpinx, trumpet Intermittent hydrosalpinx, intermittent discharge of watery fluid from the oviduct. Synonym: hydrops tubae profluens. (05 Mar 2000) |
| hydrops tubae profluens | intermittent hydrosalpinx |
| endolymphatic hydrops | A name applied to recurrent vertigo accompanied by ringing in the ears (tinnitus) and deafness. A dysfunction of the semi-circular canals (endolymphatic sac) in the inner ear. Symptoms include dizziness, hearing loss (one-sided), vertigo, nausea, vomiting and abnormal eye movements. Treatment includes anticholinergics, antihistamines and other medications which relieve vertigo. Diuretic medications have been used to lower pressure in the endolymphatic sac. (27 Sep 1997) |
| foetal hydrops | <radiology> Immune, Rh sensitization (erythroblastosis foetalis), non-immune, thalassaemia, structural defects (e.g., lung tumour), cardiac arrhythmia (secondary to conduction defect), ultrasound findings: foetal ascites and/or pleural or pericardial effusion, subcutaneous oedema, polyhydramnios, thick, hydropic placenta (12 Dec 1998) |
| rate, maternal mortality | The number of maternal deaths related to childbearing divided by the number of live births (or by the number of live births + foetal deaths) in that year. The maternal mortality rate in the united states in 1993 (and 1994) was 0.1 per 1,000 live births, or 1 mother dying per 10,000 live births. (12 Dec 1998) |
| maternal | Relating to or derived from the mother. Origin: L. Maternus, fr. Mater, mother (05 Mar 2000) |
| maternal age 35 and over | Pregnancy in women 35 or more years of age. It is used for normal pregnancies and for problems of pregnancy occurring in a woman's late reproductive years. These include effects on the mother's physical and mental health as well as risks of perinatal mortality and foetal abnormality. (12 Dec 1998) |
| maternal antibody | Any antibody transferred from a mammalian mother transplacentally into the foetus. See under immunoglobulin for details of the classes of Ig that are transferred to the foetus. (18 Nov 1997) |
| maternal behaviour | The behaviour patterns associated with or characteristic of a mother. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|